LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA–(Marketwired – June 11, 2014) – GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced positive results from two phase III studies, which showed that patients...
In the most comprehensive genetic study of the Mexican population to date, researchers have identified tremendous genetic diversity, reflecting thousands of years of separation among local populations and shedding light on a range of confounding aspects of Latino...
[June 11, 2014] (BioMed Reports Via Acquire Media NewsEdge) Below is a look at some of the headlines for companies that made news in the healthcare sector on June 11, 2014.{nfg}Orexigen Therapeutics (NASDAQ: OREX) on announced that the FDA has issued a three-month...
By a News Reporter-Staff News Editor at Cardiovascular Week — Cardiac Pacemakers, Inc. (St. Paul, MN) has been issued patent number 8740789, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors (see also Cardiac Pacemakers,...
Obesity and obstructive sleep apnea (OSA) tend to co-exist and are associated with a variety of cardiovascular risk factors, including inflammation, insulin resistance, abnormal cholesterol, and high blood pressure. While effective therapies are available for OSA,...
RSS Error: A feed could not be found at `http://www.scoop.it/t/pulmonaryrehabnews/rss.xml`; the status code is `404` and content-type is `text/html;charset=UTF-8`
